AKT1 and hepatocellular carcinoma: In combination therapy with TACE, Fuzheng Jiedu Decoction not only enhanced the killing efficiency of chemotherapeutic agents on HCC cells, but also alleviated chemotherapy-induced hepatotoxicity and myelosuppression by modulating the PI3K/AKT pathway [103, 166].